0000805928-25-000116.txt : 20250916 0000805928-25-000116.hdr.sgml : 20250916 20250916172201 ACCESSION NUMBER: 0000805928-25-000116 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20250913 FILED AS OF DATE: 20250916 DATE AS OF CHANGE: 20250916 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DeVinney Erick Wayne CENTRAL INDEX KEY: 0001595972 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36046 FILM NUMBER: 251318151 MAIL ADDRESS: STREET 1: 13631 PROGRESS BLVD SUITE 400 STREET 2: SUITE 400 CITY: ALACHUA STATE: FL ZIP: 32615 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Axogen, Inc. CENTRAL INDEX KEY: 0000805928 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 411301878 STATE OF INCORPORATION: MN FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 13631 PROGRESS BLVD. STREET 2: SUITE 400 CITY: ALACHUA STATE: FL ZIP: 32615 BUSINESS PHONE: (386) 462-6817 MAIL ADDRESS: STREET 1: 13631 PROGRESS BLVD. STREET 2: SUITE 400 CITY: ALACHUA STATE: FL ZIP: 32615 FORMER COMPANY: FORMER CONFORMED NAME: AxoGen, Inc. DATE OF NAME CHANGE: 20111004 FORMER COMPANY: FORMER CONFORMED NAME: LECTEC CORP /MN/ DATE OF NAME CHANGE: 19920703 4 1 wk-form4_1758057719.xml FORM 4 X0508 4 2025-09-13 0 0000805928 Axogen, Inc. AXGN 0001595972 DeVinney Erick Wayne 13631 PROGRESS BLVD., SUITE 400 ALACHUA FL 32615 0 1 0 0 Chief Innovation Officer 0 Common Stock 2025-09-13 2025-09-15 4 A 0 2500 0 A 221786 D Common Stock 2025-09-16 4 S 0 1137 16.29 D 220649 D This reflects the number of shares issued upon the attainment of certain performance criteria. Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of performance stock units ("PSUs") on September 13, 2025. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. /s/Erick DeVinney 2025-09-16